Pulse Biosciences (PLSE) Enterprise Value (2016 - 2026)

Pulse Biosciences has reported Enterprise Value for 11 years, with the latest figure at $1.9 billion in Q2 2026.

• On a quarterly basis, Enterprise Value rose 104.83% year-over-year to $1.9 billion in Q2 2026; TTM through Jun 2026 was $1.9 billion, a 104.83% increase from a year earlier, with the FY2025 full-year figure at $850.7 million, down 17.39% from the prior year.
• Enterprise Value was $1.9 billion for Q2 2026 at Pulse Biosciences, up from $850.7 million in the prior quarter.
• The five-year high for Enterprise Value was $1.9 billion in Q2 2026, with the low at $16.5 million in Q3 2022.
• Average Enterprise Value over 5 years is $595.5 million, with a median of $591.8 million recorded in 2024.
• The sharpest annual moves came in 2022 and 2023: Enterprise Value plunged 97.25% in 2022, then jumped 1401.35% in 2023.
• Over 5 years, Enterprise Value stood at $42.0 million in 2022, then surged by 1401.35% to $630.6 million in 2023, then jumped by 63.29% to $1.0 billion in 2024, then retreated by 17.39% to $850.7 million in 2025, then surged by 118.84% to $1.9 billion in 2026.
• The last three Enterprise Value figures came in at $1.9 billion (Q2 2026), $850.7 million (Q4 2025), and $1.1 billion (Q3 2025), per Business Quant data.